The yin and yang of kidney development and Wilms' tumors

Genes & Development
Peter HohensteinJocelyn Charlton

Abstract

Wilms' tumor, or nephroblastoma, is the most common pediatric renal cancer. The tumors morphologically resemble embryonic kidneys with a disrupted architecture and are associated with undifferentiated metanephric precursors. Here, we discuss genetic and epigenetic findings in Wilms' tumor in the context of renal development. Many of the genes implicated in Wilms' tumorigenesis are involved in the control of nephron progenitors or the microRNA (miRNA) processing pathway. Whereas the first group of genes has been extensively studied in normal development, the second finding suggests important roles for miRNAs in general-and specific miRNAs in particular-in normal kidney development that still await further analysis. The recent identification of Wilms' tumor cancer stem cells could provide a framework to integrate these pathways and translate them into new or improved therapeutic interventions.

References

Jan 1, 1979·Cytogenetics and Cell Genetics·U FranckeV M Riccardi
Oct 1, 1992·The Journal of Pathology·N R LemoineJ K Cowell
Jan 1, 1990·Pediatric Pathology·J B BeckwithJ F Bonadio
Jan 1, 1988·Cancer Genetics and Cytogenetics·M D NorrisB W Stewart
Mar 1, 1982·Cancer Genetics and Cytogenetics·R M Slater, J de Kraker
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·P M SharmaS Sukumar
Aug 27, 1993·Cell·J A KreidbergR Jaenisch
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·V SchumacherB Royer-Pokora
Jan 13, 1998·Nature Genetics·K MiyagawaN D Hastie
Jun 6, 2000·Developmental Biology·C M BatesL F Parada
Dec 11, 2002·The Journal of Pathology·Robert KoestersThomas Stallmach
Feb 28, 2003·Cancer Genetics and Cytogenetics·Melanie EhrlichJeffrey Sawyer
Mar 22, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Oliver WirthsTorsten Pietsch
Jun 5, 2003·Development·Pin-Xian XuDerek Silvius
Aug 5, 2003·The Journal of Pathology·Aswin L MenkeNicholas D Hastie
Oct 9, 2004·International Journal of Cancer. Journal International Du Cancer·Hisayuki ShigematsuAdi F Gazdar
Oct 18, 2005·Cancer Cell·Teresa M HolmRudolf Jaenisch
Dec 1, 2005·Molecular Cancer Research : MCR·Rie NishiyamaMelanie Ehrlich
Jan 6, 2007·Science·Miguel N RiveraDaniel A Haber
May 19, 2007·Science·Michael B MajorRandall T Moon
Aug 10, 2007·Nature Reviews. Cancer·Kristopher K Frese, David A Tuveson

❮ Previous
Next ❯

Citations

May 30, 2015·Kidney International·Derya D Ozdemir, Peter Hohenstein
Mar 8, 2016·Environmental Research·Javier García-PérezRebeca Ramis
Nov 10, 2015·Nature Genetics·Shazia S MahamdallieNazneen Rahman
Mar 25, 2016·BMC Nephrology·Luciana MazzeiWalter Manucha
Jul 28, 2016·EBioMedicine·Adrian Charles
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S DomeKathy Pritchard-Jones
May 28, 2017·The Journal of Biological Chemistry·Sona Lakshme BalasubramaniamSonali P Barwe
Jan 7, 2018·Acta Neuropathologica·Fabio VerginelliRenato Mariani-Costantini
Dec 27, 2018·Current Opinion in Oncology·Lixian OhHany Ariffin
Jan 30, 2019·International Journal of Cancer. Journal International Du Cancer·Illja J DietsMarkus Metzler
Jan 17, 2019·Integrative and Comparative Biology·B S de BakkerR J Oostra
Feb 25, 2017·Journal of the American Society of Nephrology : JASN·Piera Trionfini, Ariela Benigni
Feb 25, 2020·Journal of Clinical Laboratory Analysis·Rui-Xi HuaZhenjian Zhuo
Feb 1, 2018·Oncotarget·Lourdes Hontecillas-PrietoEnrique de Álava
May 16, 2020·Human Molecular Genetics·Jamie L MaciaszekKim E Nichols
Jun 28, 2020·Cancer Medicine·Ana Carolina Kerekes MiguezDirce Maria Carraro
Feb 19, 2020·Fetal and Pediatric Pathology·Li LizhiXu Di
Jul 1, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Feng ZhangHongbo Xin
Feb 2, 2019·Nature Reviews. Nephrology·Taryn Dora TregerSam Behjati
May 21, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Alexandre Góes Martini, A H Jan Danser
Mar 6, 2019·Nature Biotechnology·Frans SchutgensHans Clevers
Aug 9, 2020·Frontiers in Pediatrics·Fabiola Jimena Pérez-LinaresPilar Eguía-Aguilar
Jul 12, 2020·Journal of the American Society of Nephrology : JASN·Yishay WinebergTomer Kalisky
Sep 2, 2019·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Luciana MazzeiWalter Manucha
Nov 27, 2020·Journal of Toxicologic Pathology·Yuki NumakuraMakoto Ueda
Feb 11, 2021·The Journal of Pathology·Janna A HolRoland P Kuiper
Jun 3, 2015·Disease Models & Mechanisms·Rachel L BerryPeter Hohenstein
Jun 12, 2021·Stem Cell Reviews and Reports·Mojgan BaratiSeyedeh-Nafiseh Hassani
Sep 22, 2020·Biochemistry·Tadateru NishikawaPeter E Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Related Papers

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Naomi Pode-Shakked, Benjamin Dekel
Soins; la revue de référence infirmière
J Lemerle
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
S Kolmannskog, P J Moe
Nederlands tijdschrift voor geneeskunde
B van der Werf-Messing
Maandschrift Voor Kindergeneeskunde
R J ScholtmeijerJ J van Haga
© 2022 Meta ULC. All rights reserved